We are a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to improve outcomes in patients sufferings
We Interrogate the inner life of GPCR signaling to develop newest therapeutics.
Consetetur sadipscing elitr sediam nonumy eirmod tempoor invidunt labore magna.
Years Experience
Medicament Invented
Awards Winned
Happy Clients
Happy Clients
Balanced mix of new substance developments and life cycle management opportunities.
We focus on core competencies and its many years of experience. We thus hold a leading position in many therapeutic fields: for instance in the treatment of hemophilia and multiple sclerosis, in contrast media and oral contraception. We are also striving for such a leading position in oncology.
Consetetur sadipscing elitr diam nonumy eirmod tempor invidunt.
Ut labore et dolore magna aliquyam erat sed diam voluptua.
Consetetur sadipscing elitr diam nonumy eirmod tempor invidunt.
Ut labore et dolore magna aliquyam erat sed diam voluptua.
Balanced mix of new substance developments and life cycle management opportunities.
We focus on core competencies and its many years of experience. We thus hold a leading position in many therapeutic fields: for instance in the treatment of hemophilia and multiple sclerosis, in contrast media and oral contraception. We are also striving for such a leading position in oncology.
150 rue Elgin — 10e étage
Ottawa, ON K2P 1L4
Territoire traditionnel algonquin non cédé
Tél: 613-730-0687
Fax: 613-730-1196
N'hésitez pas à nous contacter.
L'infolettre de l'AFMC est publiée cinq fois par an et vous apporte toutes les nouvelles et informations pertinentes concernant nos initiatives et celles de nos facultés.
En insérant votre adresse électronique, vous acceptez nos Conditions générales et notre Politique de confidentialité.